BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12107376)

  • 41. Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-kappaB activation.
    Wyke SM; Russell ST; Tisdale MJ
    Br J Cancer; 2004 Nov; 91(9):1742-50. PubMed ID: 15477867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
    Sanders PM; Russell ST; Tisdale MJ
    Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats.
    Combaret L; Tilignac T; Claustre A; Voisin L; Taillandier D; Obled C; Tanaka K; Attaix D
    Biochem J; 2002 Jan; 361(Pt 2):185-92. PubMed ID: 11772390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress.
    Gomes-Marcondes MC; Tisdale MJ
    Cancer Lett; 2002 Jun; 180(1):69-74. PubMed ID: 11911972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modulation of the ubiquitin-proteasome proteolytic pathway by eicosapentaenoic acid supplementation in a model of progressive malignancy.
    Mikhail AT; Babcock TA; Jho DH; Helton WS; Brodsky IG; Espat NJ
    JPEN J Parenter Enteral Nutr; 2003; 27(2):105-9. PubMed ID: 12665165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nutritional and hormonal control of protein breakdown.
    Combaret L; Taillandier D; Attaix D
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S108-11. PubMed ID: 11158873
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids.
    Auclair D; Garrel DR; Chaouki Zerouala A; Ferland LH
    Am J Physiol; 1997 Mar; 272(3 Pt 1):C1007-16. PubMed ID: 9124503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of muscle protein degradation induced by a cancer cachectic factor.
    Lorite MJ; Thompson MG; Drake JL; Carling G; Tisdale MJ
    Br J Cancer; 1998 Oct; 78(7):850-6. PubMed ID: 9764574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms accelerating muscle atrophy in catabolic diseases.
    Mitch WE
    Trans Am Clin Climatol Assoc; 2000; 111():258-69; discussion 269-70. PubMed ID: 10881345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid.
    Smith HJ; Khal J; Tisdale MJ
    Biochem Biophys Res Commun; 2005 Jun; 332(1):83-8. PubMed ID: 15896302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway.
    Bailey JL; Wang X; England BK; Price SR; Ding X; Mitch WE
    J Clin Invest; 1996 Mar; 97(6):1447-53. PubMed ID: 8617877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
    Smith HJ; Mukerji P; Tisdale MJ
    Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer anorexia and cachexia.
    Tisdale MJ
    Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions.
    Mitch WE; Price SR
    J Ren Nutr; 2003 Apr; 13(2):149-52. PubMed ID: 12671840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging.
    Dardevet D; Sornet C; Taillandier D; Savary I; Attaix D; Grizard J
    J Clin Invest; 1995 Nov; 96(5):2113-9. PubMed ID: 7593595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
    Liu Z; Miers WR; Wei L; Barrett EJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle.
    Tiao G; Hobler S; Wang JJ; Meyer TA; Luchette FA; Fischer JE; Hasselgren PO
    J Clin Invest; 1997 Jan; 99(2):163-8. PubMed ID: 9005983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucocorticoids and muscle catabolism.
    Hasselgren PO
    Curr Opin Clin Nutr Metab Care; 1999 May; 2(3):201-5. PubMed ID: 10456248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential regulation of the lysosomal, Ca2+-dependent and ubiquitin/proteasome-dependent proteolytic pathways in fast-twitch and slow-twitch rat muscle following hyperinsulinaemia.
    Larbaud D; Balage M; Taillandier D; Combaret L; Grizard J; Attaix D
    Clin Sci (Lond); 2001 Dec; 101(6):551-8. PubMed ID: 11724638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes.
    Smith HJ; Tisdale MJ
    Br J Cancer; 2003 Nov; 89(9):1783-8. PubMed ID: 14583784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.